Re:Two Infants Treated with Universal Immune Cells Have Thei...
by tyingq on Thursday January 26, 2017 @02:06PM
(#13494253)
It appears the treatment was a single dose.
" Two infants with relapsed refractory CD19+ B cell acute lymphoblastic leukemia received lymphodepleting chemotherapy and anti-CD52 serotherapy, followed by a single-dose infusion of UCART19 cells"[1]
With that context, it's potentially cheaper than other therapies.
" Two infants with relapsed refractory CD19+ B cell acute lymphoblastic leukemia received lymphodepleting chemotherapy and anti-CD52 serotherapy, followed by a single-dose infusion of UCART19 cells"[1]
With that context, it's potentially cheaper than other therapies.
[1]http://stm.sciencemag.org/content/9/374/eaaj2013